Mesothelioma Doctors

James W. Ballard, MD
4012 Greystone Drive
Birmingham, AL 35242
email: jwballard@albreader.com Dr. Jablons is the Program Leader of the Thoracic Oncology Program at the University of California, San Francisco (UCSF) and a Program Member of the UCSF Comprehensive Cancer Center. Current research initiatives include the molecular biology of non-small cell lung cancer and mesothelioma with emphasis on gene discovery through differential display and subtraction hybridization techniques in primary tumors, metastases, and cell lines.

UCSF Comprehensive Cancer Center, Box 0128, UCSF
San Francisco, California 94143-0128
Phone: (800) 888-8664 or (415) 885-7777
Website: http://cc.ucsf.edu/index.html

Current research: http://cc.ucsf.edu/research/thoracic.html
Additional information about Dr. Jablons can be found at:
www.cc.ucsf.edu/people/jablons_david.html

Theirry Jahan, MD
2356 Sutter, 7th Floor
San Francisco, CA 94115
415–567–5581 Dr. Cameron is Assistant Professor of Surgery and the Director of Thoracic Oncology at UCLA Medical Center. He specializes in treating mesothelioma patients.

P.O. Box 951741
Los Angeles, California 90095-1741
Phone: (310) 206-8232

Mark Cullen, MD
Yale University School of Medicine
Occupational and Environmental
135 College Street, 3rd floor
New Haven, CT 06510–2483 Jack A. Elias, MD
Pulmonary Medicine
Yale Cancer Center
203–785–4163 Michael Grey, MD
UConn Health Center
263 Farmington Avenue
Farmington, CT 06032 Bruce G. Haffty, MD
Therapeutic Radiology
Yale Cancer Center
203–785–2959 Graeme L. Hammond, MD
Cardiothoracic Therapy
Yale Cancer Center
203.–785–2699 Michael Kashgarian, MD
Pathology
Yale Cancer Center
203–785–2750 Ronald Ponn, MD
Thoracic Surgeon
333 Orchard St., Suite 107
New Haven, CT 06511 Carrie A. Redlich, MD, M.P.H.
Occupational Medicine
Yale Cancer Center
203–737–2817 Dr. Robinson is the Director of the Division of Cardiovascular and Thoracic Surgery at the H. Lee Moffitt Cancer Center. He is a member of the multidisciplinary Thoracic Oncology group, which evaluates and treats all stages of mesothelioma. Clinical and research interests include aggressive surgical management of mesothelioma and advanced lung cancer.

H. Lee Moffitt Cancer Center & Research Institute
12902 Magnolia Drive
Tampa, Florida 33612-9497
Phone: (813) 972-8412
Website: www.moffitt.usf.edu
Additional information about Dr. Robinson can be found at:
www.moffitt.usf.edu/Prevention_and_Treatment/physician/details.asp

John C. Ruckdeschel, M.D. is president and chief executive officer of the Barbara Ann Karmanos Cancer Institute and Cancer Center, as well as associate dean of cancer affairs at Wayne State University’s School of Medicine. The Karmanos Cancer Institute is among 41 comprehensive cancer centers in the United States designated by the National Cancer Institute (NCI).
Website: Dr. Ruckdeschel’s Website Dr. Shin is the Professor of Hematology and Oncology at the Emory University School of Medicine and the Director of the Clinical and Translational Cancer Prevention Program at Winship Cancer Institute at Emory University. His areas of interest include head, neck and lung cancers.

Winship Cancer Institute
The Emory Clinic – C
1365 Clifton Rd, NE
Atlanta, Georgia 30322
Phone: (888) WINSHIP or (404) 778-1900
Website: www.winshipcancerinstitute.org
Additional information about Dr. Shin can be found at:
www.emoryhealthcare.org/find_physician/physician_detail.jsp?
physicianid=11592&SessionID=338213

Richard Kraiden, MD
Pulmonary Pathologist
Massachusetts General Hospital
Boston, MA 02114 Dr. Sugarbaker is the Chief of Surgical Services at the Dana-Farber Cancer Institute. He also serves as the Chief of Thoracic Surgery at Brigham and Women’s Hospital and Professor of Surgery at Harvard Medical School. Dr. Sugarbaker instituted The International Pleural Mesothelioma Program in response to the growing rise in the incidence of mesothelioma worldwide. Malignant pleural mesothelioma has been a central focus of Dr. Sugarbaker’s clinical and laboratory research, and he pioneered the “tri-modal” therapy approach.
Brigham & Women’s Hospital
Division of Thoracic Surgery
75 Francis Street
Boston, Massachusetts 02115
Phone: (617) 732-6824 Dr. Yang is the Associate Professor of Surgery and Oncology at Johns Hopkins University School of Medicine. He also serves as the Chief of the Division of Thoracic Surgery, the Director of the Lung Transplantation Program and Director of Thoracic Oncology Program at the Johns Hopkins Hospital. His primary interests include lung transplantation, video-assisted thoracic surgery (V.A.T.S.) and thoracic surgical oncology with particular interests in lung and esophageal cancer and mesothelioma.

The Johns Hopkins Hospital
Department of Surgery, Osler 624
600 North Wolfe Street
Baltimore, Maryland 21287-5674
Appointments: (410) 614-3891
Website: www.hopkinsmedicine.org
Additional information about Dr. Yang can be found at:
www.hopkinsmedicine.org/jhtop/Thoracic_Tumor_Board/Surgeons/
Stephen_Yang__M_D_/stephen_yang__m_d_.html

Dr. Kalemkerian is the Clinical Associate Professor of Medicine and the Director of the Multidisciplinary Lung Cancer Clinic at the University of Michigan Comprehensive Cancer Center. He coordinates the lung cancer research program, focusing on experimental therapeutics.

U-M Health System
Comprehensive Cancer Center
1500 E. Medical Center Drive
CCGC 6-303
Ann Arbor, Michigan 48109-0944
Phone: (800) 865-1125
Website: www.cancer.med.umich.edu
Additional information about Dr. Kalemkerian can be found at:
http://www.cancer.med.umich.edu/clinic/lungstaff.htm

Dr. Harvey Pass has dedicated his career as a thoracic surgeon to raising public awareness regarding the dangers of asbestos exposure and its direct link to pleural mesothelioma. Some of Dr. Pass’s most important research findings occurred while at the Karmanos Cancer Center, Michigan between the years of 1996-2005. Dr. Pass and his colleagues completed a key study by which they identified a protein called osteopontin that presents at elevated levels in patients diagnosed with pleural mesothelioma. This discovery enables mesothelioma physicians to use a simple blood test to screen individuals with a history of asbestos exposure in order to help diagnose pleural mesotheliomas in earlier stages where they can be treated more successfully.

NYU Langone Medical Center / School of Medicine
530 First Avenue,
New York, NY 10016
(212) 263-7300>
Website: Dr. Harvey Pass

Arkadiusz Dudek, M.D., Ph.D.
Assistant professor of medicine
Phone: 612-624-0123
Email: dudek002@umn.edu Dr. Harpole is an Associate Professor of Surgery in the Division of Thoracic Surgery at Duke University Medical Center. He specializes in thoracic oncology, general thoracic surgery, and benign and malignant diseases of the lung, esophagus, and mediastinum.

Duke University Medical Center
2400 North Pratt Street
Room 0311 Terrace Level
Durham, North Carolina 27705
Phone: (919) 668-8413
Website: http://dukehealth1.org/surgery/div_cardio.asp

Additional information about Dr. Harpole can be found at:
http://dukehealth1.org/physician_search/details.asp?
unid=0EDDEBB41A132412852569920080C9FD

Dr. Loggie is Professor of Surgery, Chief of the Division of Surgical Oncology, and Director of the Cancer Center at Creighton University Medical Center. He specializes in the treatment of peritoneal mesothelioma and peritoneal carcinomatosis. His research protocol involves surgical debulking in combination with intraperitoneal heated chemotherapy.

Creighton University Medical Center
Division of Surgical Oncology, Suite 3700
601 North 30th Street
Omaha, Nebraska 68131
Phone: (402) 280-5009
Website: http://medicine.creighton.edu/surgery
Additional information about Dr. Loggie can be found at:
http://medicine.creighton.edu/surgery/faculty/loggie.htm

David Kern, MD
Memorial Hospital of RI
Occupational Health Clinic
111 Brewster Street
Pawtucket, RI 02860 Dr Claire Verschraegen – Albuquerque – New Mexico Dr. Vogelzang is the Director of the Nevada Cancer Institute. He previously served as the Director of the University of Chicago Cancer Research Center and a medical oncologist with the University of Chicago Cancer Research Center Mesothelioma Program. His interests are in clinical trials in genitourinary malignancies and mesothelioma. He is a recognized expert in new therapies for patients with metastatic kidney cancer, including genetic therapy, new cytokine therapy, and combination.

Nevada Cancer Institute
10000 W. Charleston Blvd., Suite 260
Las Vegas, Nevada 89135
Phone: (702) 821-0000

Manjit Bains, MD
Memorial Sloan Kettering Cancer Center
1275 York Avenue
New York, NY 10021 Philippe A. Chihanian, MD
Mt. Sinai Hospital
5 East 98 St.
New York, NY 10029
212–241–6368 David Ilson, MD
Borys Mychalczak, MD
Sloan–Kettering Cancer Center
New York, NY Dr. Rusch specializes in treating patients with cancers of the lung, esophagus, mediastinum, and chest wall, including those with mesothelioma. Her research interests include the genetics of lung cancer and mesothelioma and predicting how a patient will respond to a particular treatment. She is also involved in developing methods for early detection of thoracic cancers.

Memorial Sloan-Kettering Cancer Center
1275 York Avenue
New York, New York 10021
Phone: (212) 639-5873
Website: www.mskcc.org
Additional information about Dr. Rusch can be found at:
http://www.mskcc.org/prg/prg/bios/51.cfm

Stephen Rush, MD
North Shore University Hospital
Manhasset, NY Dr. Perez-Soler is the Associate Director of Clinical Oncology at New York University Kaplan Cancer Center in New York, NY. He specializes in medical oncology and is the principal investigator of the Phase II L-NDDP/Platar trial for pleural mesothelioma.

Recent publications:
http://library.med.nyu.edu/cgi-bin/facbib-bio.pl?
AU=perezr01&RP=N&CP=N
New York University School of Medicine
550 First Avenue
New York, New York 10016
Phone: (212) 263-8043
Website: www.med.nyu.edu
Additional information about Dr. Perez-Soler can be found at:
http://www.med.nyu.edu/people/perezr01.html

Dr. Taub is the Professor of Clinical Medicine at Columbia University, College of Physicians and Surgeons and a medical oncologist who directs the Connective Tissue Oncology Program at the Herbert Irving Comprehensive Cancer Center, where there are several ongoing multimodality studies of patients with pleural and peritoneal mesothelioma.

Columbia University College of Physicians and Surgeons
161 Fort Washington Avenue
Herbert Irving 9-907
New York, New York 10032
Phone: (212) 305-4076
Website: www.nyp.org
Additional information about Dr. Taub can be found at:
http://www.beryl.net/custom/physref/nyp/PhysDetail.asp

Dr. Keohan is the Assistant Professor of Clinical Medicine at Columbia University College of Physicians and Surgeons and New York Presbyterian Hospital. She is a medical oncologist who specializes in the treatment of mesothelioma, sarcoma and Kaposi’s sarcoma at the Herbert Irving Comprehensive Cancer Center, where there are a number of ongoing multimodality studies of patients with pleural and peritoneal mesothelioma as well as other connective tissue oncology studies.

Columbia-Presbyterian Medical Center
161 Fort Washington Avenue
Herbert Irving Pavilion, Suite 9-917
New York, New York 10032
Phone: (212) 305-0549
Website: www.cumc.columbia.edu/dept/medicine/sarcoma/irving.html

Dr. Friedberg is the Director of the Division of Thoracic Surgery at Thomas Jefferson University Hospital in Philadelphia, PA. His interests are in all areas of thoracic surgery, including benign and malignant pulmonary diseases and malignant mesothelioma.

Thomas Jefferson University Hospital
1100 Walnut Street
Philadelphia, Pennsylvania 19107
Phone: (800) JEFF-NOW or (215) 955-2996
Website: www.jeffersonhospital.org/surgery

Dr. Kaiser is a cardiothoracic surgeon and the co-director of the Thoracic Oncology Research Lab. His work in the laboratory focuses on gene therapy of thoracic tumors. He also serves as the John Rhea Barton Professor and Chairman of the Department of Surgery as well as the Eldridge L. Eliason Professor of Surgery and Chief of Surgery at the Hospital of the University of Pennsylvania. His areas of interest include malignant mesothelioma and mediastinal tumors.

3400 Spruce Street
4 Silverstein Pavilion
Philadelphia, Pennsylvania 19104-4227
Patient Appointments: (215) 662-2050
Website: http://www.uphs.upenn.edu/lungctr/academic_programs/pulmonary/
research/labs/albelda/torl/torl_home.html

Additional information about Dr. Kaiser can be found at:
http://www.uphs.upenn.edu/lungctr/academic_programs/pulmonary/
research/labs/albelda/torl/people.html

Dr. Sterman is the Assistant Professor of Medicine at the University of Pennsylvania Medical Center in Philadelphia, PA. He is also the Clinical Director of the Thoracic Oncology Gene Therapy Program. His clinical interests include the treatment of thoracic malignancies as they apply to the development and implementation of new techniques in interventional pulmonology.

University of Pennsylvania Medical Center
Pulmonary, Allergy & Critical Care Division
833 West Gates Building
3400 Spruce Street
Philadelphia, Pennsylvania 19104-4283
Phone: (215) 614-0984
Website: www.uphs.upenn.edu/lungctr/academic_programs/pulmonary
Additional information about Dr. Sterman can be found at:
http://www.uphs.upenn.edu/lungctr/academic_programs/pulmonary/
provider_profiles/dsterman.html

David Ettensohn, MD
Pulmonary Medicine
109 Beechwood Avenue
Pawtucket, RI John Pella, MD
St. Joseph Hospital
Pulmonary Fatima Unit
200 High Service Avenue
North Providence, RI 02904 S.T. Sambandan, MD
Oncologist
1180 Hope Street
Bristol, RI Anthony Testa MD
Oncologist
100 Highland Avenue
Providence, RI 02904 James Bradof, MD
406 Tiffany Park
Gaffney, SC Spencer McCachren, MD
Thompson Cancer Center
Knoxville, TN
423–541–1812 Dr. Smythe is the Associate Professor and Director of the Mesothelioma Multidisciplinary Treatment and Research Program at the University of TX MD Anderson Cancer Center. He has designed a pilot protocol at MD Anderson for malignant pleural mesothelioma involving aggressive surgical therapy followed by intensity modulated radiation therapy (IMRT). His research interests include prodrug gene therapy, apoptosis, mesothelioma, and lung neoplasms.

Curriculum Vitae:
http://www.mdanderson.org/departments/tcvsurg/
display.cfm?id=6e6eec3d-29ac-4c21-93f115c507c4105b&method=
displayfull&pn=8569ad4f-955b-11d4-80fa00508b603a14

Department of Thoracic and Cardiovascular Surgery
1515 Holcombe Boulevard, Box 445
Houston, Texas 77030-4095
Phone: (713) 792-6933
Appointments: (713) 792-6161 or (800) 392-1611
Website: www.mdanderson.org
Additional information about Dr. Smythe can be found at:
http://www.mdanderson.org/departments/tcvsurg/
display.cfm?id=8569b58f-955b-11d4-80fa00508b603a14&method=
displayfull&pn=8569ad4f-955b-11d4-80fa00508b603a14

Claire Verschraegen, MD
Department Of Clinical Investigation
University of Texas, MD Anderson Cancer Center
1515 Holcombe Blvd., Box 39, Rm. R7.2215
Houston, Texas 77030
Phone: 713–792–7959 Samuel Hammer, MD
700 Lebo Road
Bremerton, WA 98310
360–479–7707 Dr. Eric Vallières is a thoracic surgeon, who joined the Swedish Cancer Institute (SCI) to help lead its multidisciplinary Lung Cancer Program. Dr. Vallières is recognized nationally and internationally as an expert in, and a proponent of, the benefits of multi-modality therapy for lung-cancer patients. In addition to lung cancer, Dr. Vallières’ areas of expertise include mesothelioma, thoracic oncology and the surgical treatment of hyperhidrosis. Internationally recognized for his clinical research in lung cancer, he has been the recipient of numerous grants for conducting clinical trials and has published more than 120 articles and abstracts.

Swedish Cancer Institute
First Hill Campus
1221 Madison St.
Seattle, Washington 98104
Phone: (206) 386-2525
Website: http://www.swedish.com/body.cfm?id=37&oTopID=19